Wenqi Cui

PhD in pharmacology and toxicology. Studying NAFLD NASH & liver fibrosis. An okay person navigating this intriguing world

[Wenqi Cui @VickyNewStart]

@NASH_and_coffee @pgholam @UHhospitals Haha I guess I need to stock up tapes this Black Friday 🤣

[Wenqi Cui @VickyNewStart]

@NASH_and_coffee @LilaGonzalezH My application is attached. Summary of qualifications: I work for the Rotman lab and I serve @RotmanLabShark I swear under her fin I will keep her afloat in your absence.

[NIH Intramural @IRPatNIH]

An underrated powerhouse, the #liver aids with detoxification and digestion, but its ability to store fat can contribute to #FattyLiverDisease. Read about how @NIDDKgov #NIH_IRP Senior Investigator Yaron Rotman @NASH_and_coffee is studying this: https://t.co/BBd3GvFAOZ

[Yaron Rotman @NASH_and_coffee]

Dr. @VickyNewStart from the @NIDDKgov #Rotmanlab deciphering how #HSD17B13 improved fibrosis in a mouse #NASH model at @AASLDtweets #TLM22

[NIDDK @NIDDKgov]

#ICYMI: NIDDK research in @AGA_Gastro shows that
people and mice with nonalcoholic fatty liver disease (NAFLD) have sustained post-meal increases in lipids called diacylglycerols. https://t.co/XjhMmNIKwD
@theNCI @NIHClinicalCntr @AmerGastroAssn @NASH_and_coffee #RotmanLab

[AASLD @AASLDtweets]

October is National #Liver Awareness Month! How do you protect your liver? Eating a balanced diet, watching your weight, and staying active can help you avoid liver diseases. You only have one liver, and you can't live without it. So, take actions today to stay healthy and happy.

[Wenqi Cui @VickyNewStart]

@NASH_and_coffee Agreed! The publishers should also establish guidelines for reviewers to provide only constructive comments and respectful feedbacks.

[Yaron Rotman @NASH_and_coffee]

The Steato-Hepatitis And Running Klub (SHARK) team from the @NIDDKgov #RotmanLab aced* the @NIH relay race today, shark in hand!

* finished**
** barely

@VickyNewStart
(Photo credit @TimGreten)

[Dr. Glaucomflecken @DGlaucomflecken]

Big news in academic publishing!

[Boehringer Ingelheim @Boehringer]

#RESEARCHERS: Take a chance and join our efforts to unravel the many unknown roles of HSD17B13 in human diseases when expressed in other cell types than hepatocytes. Discover more on #opnMe.

[Journal of Lipid Research @jlipidres]

Lopresti et al. find that hepatic overexpression of LAL drove immune cell infiltration and inflammation and did not attenuate the development of NAFLD, suggesting that targeting LAL expression may not be a viable route to treat NAFLD in humans ― @dgmashek
https://t.co/u7hycRGXlm

[Wenqi Cui @VickyNewStart]

Only the ones have been tortured know the pain 😫